Irene Hernaez, DPM
Podiatrist · Sugar Land, TXNPI 1184624892
Payments from drug & device makers
Across 231 payments — averaging $42.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paratek Pharmaceuticals, Inc.$2K
- Paragon 28, Inc.$2K
- Arthrosurface Incorporated$1K
- Musculoskeletal Transplant Foundation Inc.$911
- Smith+Nephew$628
- Amgen$375
- plus $3K from 29 others
What the payments were for
- Travel & lodging$3,20532%
- Food & beverage$6,72268%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 91 | $2,277 |
| Paragon 28, Inc. | 4 | $1,911 |
| Arthrosurface Incorporated | 11 | $1,050 |
| Musculoskeletal Transplant Foundation Inc. | 5 | $911 |
| Smith+Nephew | 30 | $628 |
| Amgen(2 entities) | 9 | $375 |
| Melinta Therapeutics, LLC | 21 | $366 |
| Stryker | 7 | $234 |
| Reddress USA, Inc. | 1 | $225 |
| Treace Medical Concepts, Inc. | 8 | $222 |
| Averitas Pharma Inc. | 6 | $204 |
| Kerecis Limited | 2 | $202 |
| AbbVie | 2 | $146 |
| Bone Support Inc. | 1 | $144 |
| Mimedx Group, Inc. | 2 | $132 |
| Next Science LLC | 1 | $118 |
| Alafair Biosciences, Inc. | 1 | $116 |
| Organogenesis Inc. | 1 | $98 |
| Bioventus LLC | 4 | $82 |
| Osiris Therapeutics Inc. | 4 | $80 |
| Hartmann USA, Inc. | 3 | $63 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $58 |
| Globus Medical | 2 | $57 |
| Keswick Pharmaceuticals LLC | 1 | $38 |
| Medinc Of Texas | 1 | $31 |
| Cashflow Solutions, LLC | 2 | $24 |
| Amniox Medical, Inc. | 1 | $23 |
| Integra Lifesciences Corporation | 1 | $20 |
| Biotissue Holdings Inc. | 1 | $19 |
| Zyla Life Sciences, Inc. | 1 | $17 |
| Heron Therapeutics, Inc. | 1 | $14 |
| Convatec Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Arteriocyte Medical Systems, Inc. | 1 | $11 |
| Glenmark Therapeutics Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Product Portfolio$1,128
- HemiCAP MTP Resurfacing$805
- Kerecis Omega3 Marigen$743
- Portfolio$695
- NUZYRA$582
- KRYSTEXXA$246
- Kerecis Omega3 SurgiClose$186
- CERAMENTBONE VOID FILLER$144
- Grafix$135
- STRAVIX PL$135
- DALVANCE$125
- REGRANEX$123
- Lapiplasty System$120
- Xperience$118
- BlastX$118
- VersaWrap$116
How this compares
$9,927 in reported general payments places this provider in the 80th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 88 | $3,159 |
| Ammonium Lactate | 62 | $919 |
| Terbinafine Hcl | 42 | $915 |
| Cephalexin | 62 | $556 |
| Ketoconazole | 21 | $520 |
| Diclofenac Sodium | 16 | $514 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 15 | $250 |
| Mupirocin | 27 | $238 |
| Gabapentin | 14 | $191 |
| Allopurinol | 12 | $71 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $49 |
| Amoxicillin | 11 | $21 |
| Meloxicam | 11 | $21 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Sugar Land
- Porsha MelcherSugar Land$14K
- Brian CarpenterFort Worth$1.2M
- Gary LepowHouston$1M
- Travis MotleyFort Worth$888K
- Wayne HurstCedar Park$625K
- Calvin RushingSunnyvale$462K
- Lena LevineFort Worth$298K
- Robert TaylorFrisco$280K
- Alan GarrettFort Worth$236K
- Patrick BriggsWebster$236K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.